Boosting CAR-T to treat solid tumors with a vaccine

Boosting CAR-T to treat solid tumors with a vaccine

Source: 
Fierce Biotech
snippet: 

Therapeutic cancer vaccines direct a person’s own immune cells against tumors. What if we could use that approach to prime CAR-T cells so that they could work against solid tumors? A platform to do just that has been licensed to Elicio Therapeutics, which nabbed $30 million to help fund its first human studies.